IDLDX — IDL Diagnostics AB (publ) Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for IDL Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12	37	43	57.4	53.1
Cost of Revenue
Gross Profit	-5.04	-2.1	-2.1	11.7	27.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	62.6	96.3	103	101	65.1
Operating Profit	-50.6	-59.3	-59.8	-43.4	-12
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-50.6	-59.3	-59.3	-42.4	-12.2
Provision for Income Taxes
Net Income After Taxes	-50.6	-59.3	-59.3	-42.4	-12.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	-50	-59	-59.3	-42.4	-12.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-50	-59	-59.3	-42.4	-12.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.32	-0.09	-0.086	-0.012	-0.053
Dividends per Share